Abbott Laboratories - 45 Year Stock Price History | ABT

Historical daily share price chart and data for Abbott Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Abbott Laboratories as of July 25, 2025 is 126.54.
  • The all-time high Abbott Laboratories stock closing price was 138.95 on March 03, 2025.
  • The Abbott Laboratories 52-week high stock price is 141.23, which is 11.6% above the current share price.
  • The Abbott Laboratories 52-week low stock price is 102.78, which is 18.8% below the current share price.
  • The average Abbott Laboratories stock price for the last 52 weeks is 122.96.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Abbott Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 128.7748 111.8260 138.9500 110.0940 126.5400 13.49%
2024 109.0029 106.1630 117.6910 98.1786 111.5000 4.82%
2023 99.9225 103.8250 110.1630 87.1629 106.3760 2.26%
2022 105.1687 129.5640 129.5640 90.0677 104.0240 -20.68%
2021 112.5723 100.1260 131.8190 97.8283 131.1480 30.53%
2020 87.7181 78.5522 104.9990 56.9938 100.4750 28.04%
2019 72.3175 61.7632 79.8492 58.8483 78.4709 22.08%
2018 56.6904 51.3052 66.0022 49.3408 64.2781 29.06%
2017 42.0311 33.3057 50.1532 33.3057 49.8042 52.03%
2016 34.1965 35.7159 38.3837 30.4241 32.7598 -12.32%
2015 38.1965 36.5806 42.3522 32.3101 37.3632 1.87%
2014 33.0898 30.4643 37.7782 28.7275 36.6783 20.08%
2013 28.2308 25.1294 30.8468 25.1294 30.5440 23.96%
2012 23.3335 20.6622 27.1351 19.8962 24.6409 20.30%
2011 18.3387 16.7891 20.5201 16.0025 20.4837 21.78%
2010 17.5650 18.4966 19.2407 15.8217 16.8207 -8.27%
2009 16.2315 17.5980 18.9467 13.8659 18.3370 4.57%
2008 17.9291 17.8737 19.5108 16.2476 17.5356 -2.49%
2007 17.2651 15.3152 18.8633 15.3152 17.9826 18.04%
2006 13.9421 12.0446 15.3766 12.0446 15.2339 26.86%
2005 13.6801 13.8854 15.0421 11.4599 12.0080 -13.48%
2004 11.9390 11.8198 13.9806 10.0040 13.8794 17.80%
2003 10.3427 9.8905 11.9209 8.5407 11.7819 19.27%
2002 11.2130 13.5043 14.0074 7.6109 9.8781 -26.73%
2001 12.0308 11.4416 13.7292 10.0441 13.4825 17.08%
2000 9.8571 8.1709 13.2543 6.9501 11.5158 35.84%
1999 10.1182 11.2142 12.2566 7.7769 8.4773 -24.79%
1998 9.3600 7.6418 11.4443 7.5567 11.2717 51.86%
1997 6.9323 5.5826 7.7763 5.5826 7.4222 31.97%
1996 4.9862 4.5289 6.2891 4.2246 5.6241 24.56%
1995 4.1400 3.4746 4.8156 3.3353 4.5153 30.45%
1994 3.1172 2.9862 3.5674 2.7174 3.4613 12.97%
1993 2.7477 3.0632 3.1026 2.3569 3.0638 0.02%
1992 3.0698 3.3267 3.3741 2.6944 3.0632 -10.09%
1991 2.5581 2.0978 3.4071 1.9381 3.4071 56.10%
1990 1.8353 1.6437 2.2069 1.5030 2.1827 35.24%
1989 1.3910 1.1067 1.6645 1.0875 1.6140 44.70%
1988 1.0745 1.0998 1.1823 0.9835 1.1154 2.21%
1987 1.2962 1.0614 1.5007 0.9725 1.0913 7.04%
1986 0.9739 0.7452 1.2042 0.7023 1.0195 36.06%
1985 0.5919 0.4335 0.7685 0.4281 0.7493 68.19%
1984 0.4528 0.4775 0.5082 0.4054 0.4455 -5.15%
1983 0.4679 0.3760 0.5502 0.3741 0.4697 19.27%
1982 0.3256 0.2744 0.4078 0.2578 0.3938 43.51%
1981 0.2870 0.2890 0.3214 0.2439 0.2744 -4.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $220.159B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $157.028B 37.51
Stryker (SYK) United States $154.023B 32.21
EssilorLuxottica (ESLOY) France $136.572B 0.00
Medtronic (MDT) Ireland $119.200B 16.90
Lonza Group Ag (LZAGY) Switzerland $50.282B 0.00
Haleon (HLN) United Kingdom $44.384B 25.33
ResMed (RMD) United States $40.346B 30.30
GE HealthCare Technologies (GEHC) United States $35.536B 16.87
Agilent Technologies (A) United States $34.139B 22.26
Terumo (TRUMY) Japan $25.843B 33.57
Koninklijke Philips (PHG) Netherlands $25.190B 17.68
Insulet (PODD) United States $20.424B 80.17
Zimmer Biomet Holdings (ZBH) United States $19.300B 12.40
Baxter (BAX) United States $14.995B 11.19
Smith & Nephew SNATS (SNN) United Kingdom $13.871B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.189B 25.02
Lantheus Holdings (LNTH) United States $5.046B 12.73
Perrigo (PRGO) Ireland $3.908B 9.91
Prestige Consumer Healthcare (PBH) United States $3.799B 16.97
Haemonetics (HAE) United States $3.613B 16.45
Envista Holdings (NVST) United States $3.525B 29.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.197B 23.58
LeMaitre Vascular (LMAT) United States $1.862B 41.63
QuidelOrtho (QDEL) United States $1.852B 12.74
AtriCure (ATRC) United States $1.559B 0.00
Acuren (TIC) United States $1.441B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.95
AdaptHealth (AHCO) United States $1.274B 12.93
Phibro Animal Health (PAHC) United States $1.183B 15.12
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.080B 0.00
Curaleaf Holdings (CURLF) Canada $0.964B 0.00
InMode (INMD) Israel $0.930B 9.38
Kestra Medical Technologies (KMTS) United States $0.850B 0.00
Tilray Brands (TLRY) Canada $0.693B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.685B 0.00
Valneva SE (VALN) France $0.654B 0.00
Evolus (EOLS) United States $0.614B 0.00
Owens & Minor (OMI) United States $0.609B 5.05
CeriBell (CBLL) United States $0.547B 0.00
ZimVie (ZIMV) United States $0.521B 23.70
Surmodics (SRDX) United States $0.515B 0.00
SNDL (SNDL) Canada $0.398B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.359B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Capricor Therapeutics (CAPR) United States $0.322B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Aurora Cannabis (ACB) Canada $0.272B 80.67
Cerus (CERS) United States $0.266B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.242B 20.40
Biote (BTMD) United States $0.236B 6.65
Canopy Growth (CGC) Canada $0.234B 0.00
Verano Holdings (VRNOF) United States $0.230B 0.00
Sanara MedTech (SMTI) United States $0.227B 0.00
Omeros (OMER) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Organigram Global (OGI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.65
High Tide (HITI) Canada $0.188B 0.00
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.155B 0.00
TerrAscend (TSNDF) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.121B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Jushi Holdings (JUSHF) United States $0.101B 0.00
Fonar (FONR) United States $0.100B 12.86
Quipt Home Medical (QIPT) United States $0.097B 0.00
Apyx Medical (APYX) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.082B 0.00
Zynex (ZYXI) United States $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 13.29
Nephros (NEPH) United States $0.038B 51.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00